Trial Profile
Phase I study on tolerability of AVN 211 for treatment of Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2013
Price :
$35
*
At a glance
- Drugs AVN 211 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
- 18 Nov 2008 New trial record.
- 03 Nov 2008 This trial is expected to be initiated in 2009, according to an Avineuro Pharmaceuticals media release.